Your browser doesn't support javascript.
loading
Modified pustulotic arthro-osteitis diagnostic guidance 2022 - Modified Sonozaki criteria - Secondary publication.
Tsuji, Shigeyoshi; Okubo, Yukari; Kishimoto, Mitsumasa; Taniguchi, Yoshinori; Ishihara, Yoko; Tamura, Masao; Kobayashi, Satomi; Watanabe, Rei; Takakubo, Yuya; Tomita, Tetsuya.
Afiliación
  • Tsuji S; Department of Rehabilitation, Orthopaedic Surgery, Psoriasis Center, Nippon Life Hospital, Osaka, Japan.
  • Okubo Y; Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
  • Kishimoto M; Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
  • Taniguchi Y; Department of Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi Medical School Hospital, Kochi University, Nankoku, Kochi, Japan.
  • Ishihara Y; Department of Dermatology, Seibo International Catholic Hospital, Tokyo, Japan.
  • Tamura M; Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan.
  • Kobayashi S; Department of Dermatology, Seibo International Catholic Hospital, Tokyo, Japan.
  • Watanabe R; Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Takakubo Y; Department of Integrative Medicine for Allergic and Immunological Diseases, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Tomita T; Department of Orthopaedic Surgery & Rehabilitation, Yamagata University Faculty of Medicine, Yamagata, Japan.
Mod Rheumatol ; 34(5): 1076-1078, 2024 Aug 20.
Article en En | MEDLINE | ID: mdl-38300513
ABSTRACT
The concept of pustulotic arthro-osteitis (PAO) was first reported by Sonozaki et al. in 1979, with diagnostic criteria (Sonozaki criteria) proposed in 1981. These criteria have served as the gold standard for PAO diagnosis for over 40 years. In recent years, there has been an increasing emphasis on maximizing the quality of life of patients with PAO. This is achieved by striving for clinical remission, structural remission, and functional remission through early diagnosis and appropriate therapeutic intervention from an early stage. This article is an English translation of a summary of the 'Modified PAO Diagnostic Guidance 2022', edited by the Japan Ministry of Health, Labour and Welfare's Research Group on improvement of medical standard and quality of life of patients with spondyloarthritis and related diseases represented by ankylosing spondylitis and the Japan Spondyloarthritis Society. This guidance is intended to be helpful to both Japanese and global communities in rheumatology and spondyloarthritis.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteítis Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Mod Rheumatol Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteítis Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Mod Rheumatol Año: 2024 Tipo del documento: Article País de afiliación: Japón